Caroline Seymour

Managing Editor, OncLive®
Caroline Seymour is your initial point of contact for the OncLive® podcast, OncLive On Air™. She joined the company in 2018 as an assistant editor, with expertise in video production and print/digital publication. Email: cseymour@onclive.com

Articles

Adjuvant Setting in ER-Positive Breast Cancer Undergoing Transformation

April 13th 2018

Ruta D. Rao, MD, elaborates on the findings of the ABCSG-16, SOFT, and TEXT clinical trials and how they have shaped adjuvant treatment for ER-positive breast cancer.

Role of Immunotherapies Emerging in Gastric/GEJ Cancers

April 11th 2018

Andrew Ko, MD, discusses how the approval of pembrolizumab has impacted patients with positive PD-L1 expression and how clinical trials that have reshaped the standard of care in patients with gastric and GEJ cancers.

HCC Trials Spur Treatment Landscape Forward

April 11th 2018

R. Kate Kelley, MD, discusses the incidence of and risk factors for HCC, and emphasizes the sequence of clinical trials that characterized the field in 2017.

Role of Surgery Could Change Following Durvalumab Approval for Stage III NSCLC

April 11th 2018

Benny Weksler, MD, FACS, discusses the use of surgery in a biomarker-driven and drug-dependent era and highlights other cases in which surgery can benefit patients with NSCLC.

Neoadjuvant, Nonoperative Regimens Being Investigated in Rectal Cancer

April 10th 2018

Katherine Van Loon, MD, MPH, discusses the emerging use of neoadjuvant therapy and nonoperative approaches for patients with locally advanced rectal cancer.

Tempero Spotlights Frontline Treatment Options in Pancreatic Cancer

April 10th 2018

Margaret A. Tempero, MD, discusseds frontline treatment options in pancreatic cancer and emphasized the use and difficulties of conventional and incoming therapies across disease states.

Standardization, Simplification Needed for Wider Adoption of Robotic Cystectomy

April 10th 2018

Amit Gupta, MD, discusses the superiority of robotic cystectomy compared with open cystectomies and its relevance in the current treatment landscape of bladder cancer.

Expert Discusses Developments in Follicular Lymphoma

April 9th 2018

Lori Ann Leslie, MD, provides expert insight on the latest developments in the field of follicular lymphoma.

MCL Leader Discusses Optimal Disease Management

April 5th 2018

Andre Goy, MD, discusses the evolution of MCL treatment, specifically the integration of new agents in both the frontline and relapsed/refractory settings, and the importance of MRD status and maintenance therapies.

Ongoing Advances Transforming Treatment in Myeloma

April 2nd 2018

Noa Biran, MD, discusses treatment breakthroughs and emerging advances in the field of multiple myeloma.

Multimodal Approaches Emerging in Locally Advanced Prostate Cancer

April 1st 2018

Edouard J. Trabulsi, MD, discusses emerging multimodal treatment approaches for patients with locally advanced prostate cancer.

Surgical Techniques Continue to Evolve in NSCLC

March 29th 2018

Jason M. Long, MD, discusses the latest developments with minimally invasive surgical approaches in the treatment of patients with non–small cell lung cancer (NSCLC).

Challenges Continue With Lung Cancer Screening

March 28th 2018

M. Patricia Rivera, MD, discusses the potential of lung cancer screening, challenges in its adoption, and methods to enhance its efficacy.

Immunotherapy, Sidedness Strategies Enhancing mCRC Treatment

March 23rd 2018

Chloe E. Atreya, MD, PhD, discusses the latest treatment advances in mCRC, including tumor sidedness and emerging immunotherapy strategies.

Traina Talks TNBC Treatment Evolution

March 23rd 2018

Tiffany A. Traina, MD, discussed the potential for PARP inhibitors, as well as immunotherapy and antibody-drug conjugates, for the treatment of patients with triple-negative breast cancer.

Expert Highlights Precision Medicine Advances in GI Cancers

March 21st 2018

Eric A. Collisson, MD, discusses ongoing efforts to advance precision medicine in GI malignancies to improve the standard of care.

Expert Makes Case for Hypofractionation in Prostate Cancer

March 19th 2018

Howard M. Sandler, MD, discusses the emergence of hypofractionation as a viable treatment approach for patients with prostate cancer.

Chemotherapy May Be Vital to Long-Term Immunotherapy Efficacy in Bladder Cancer

March 14th 2018

Parminder Singh, MD, discusses the potential of immunotherapy, the importance of sequencing to avoid disease progression, and the use of chemotherapy and radiation therapy to reach an unmet need in muscle-invasive bladder cancer.

Expert Discusses Optimizing HIFU and Other Strategies in Prostate Cancer

March 14th 2018

Timothy J. Daskivich, MD, discusses the use of High-intensity focused ultrasound and other treatment strategies in the prostate cancer armamentarium.

Expert Discusses Developments, Challenges With Radiation in NSCLC

March 13th 2018

Holger L. Gieschen, MD, discusses the latest developments with radiation therapy in non-small cell lung cancer.